ArticleBlood advances2023

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc.

Julie O'Neal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.